Oncological problems in pancreatic cancer surgery

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

310

HTML

2585

Figures (1-3)

208

Tables (1-6)

217

Sum=3320

Jul 28, 2006 (publication date) through Nov 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 28, 2006; 12(28): 4466-4472
Published online Jul 28, 2006. doi: 10.3748/wjg.v12.i28.4466

Table 5 Reports of occult lymph node metastasis

Author	Yr	Results
Tian et al[79]	1992	HE: 8/56 (14%) Cytokeratin: 17/56 = (30%)
Ando et al[80]	1997	K-ras: paraaortic lymph nodes: 42/101 (42%)
Demeure et al[81]	1998	K-ras: Stage I (T1-2, N0, M0) 16/22 (73%)
Yamada et al[82]	2000	K-ras (-) has a better prognosis than K-ras (+)
Bogoevski et al[83]	2004	Ber–EP4: immunostaining 56/148 (37.8%)

Citation: Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, Inoue S, Takeda S. Oncological problems in pancreatic cancer surgery. World J Gastroenterol 2006; 12(28): 4466-4472
URL: https://www.wjgnet.com/1007-9327/full/v12/i28/4466.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i28.4466